IGM Biosciences Inc (IGMS) — Cash Flow Reinvestment Rate
Latest as of June 2022:
1.67x
IGM Biosciences Inc (IGMS) has a Cash Flow Reinvestment Rate of 1.67x as of June 2022, reinvesting $185.78 Million (capex $1.82 Million plus investments $-183.96 Million) from operating cash flow of $111.29 Million. See how much free cash does IGM Biosciences Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
1.67x
(Capex + Investments) / Operating CF
Total Reinvested
$185.78 Million
Capex + Investments
Operating Cash Flow
$111.29 Million
USD
Capital Expenditures
$1.82 Million
USD
Annual Cash Flow Reinvestment Rate for IGM Biosciences Inc (None–None)
Year-by-year capital reinvestment analysis for IGM Biosciences Inc. See IGMS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow